Herz- und Diabeteszentrum Nordrhein-Westfalen


Hospital

Location:
Bad Oeynhausen, Germany


Publications in cooperation with FAU scientists


Gocht, A., Distler, J., Spriewald, B., Ramsperger-Gleixner, M., Ensminger, S.M., Weyand, M., & Heim, C. (2018). Blockade of Tyrosine Kinases as Preventive Strategy Against Cardiac Allograft Vasculopathy in a Murine Aortic Transplant Model. (pp. S452-S452).
Gocht, A., Distler, J., Spriewald, B., Ramsperger-Gleixner, M., Weyand, M., Ensminger, S.M., & Heim, C. (2018). Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts. Transplant Immunology, 49, 43-53. https://dx.doi.org/10.1016/j.trim.2018.04.002
Heim, C., Gocht, A., Distler, J., Spriewald, B., Ramsperger-Gleixner, M., Weyand, M., & Ensminger, S.M. (2018). PDGF Receptor Blockade is Associated With Decreased Development of Cardiac Allograft Vasculopathy in a Murine Aortic Transplant Model. (pp. S126-S126).
Kroencke, S., Greif-Higer, G., Albert, W., De Zwaan, M., Erim, Y., Eser-Valeri, D.,... Kuensebeck, H.-W. (2018). Psychosocial Evaluation of Transplant Patients - Recommendations for the Guidelines for Organ Transplantation. Psychotherapie Psychosomatik Medizinische Psychologie, 68(5), 179-184. https://dx.doi.org/10.1055/s-0044-102294
Gocht, A., Spriewald, B., Distler, J., Ramsperger-Gleixner, M., Ensminger, S.M., Weyand, M., & Heim, C. (2018). Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts. Transplantation Direct, 4(7). https://dx.doi.org/10.1097/TXD.0000000000000804
Miera, O., Schmitt, K.R., Menon, A.K., Ersel, S., Reiprich, A., Akintuerk, H.,... Amodeo, A. (2017). Current Practice of Anticoagulation for Pediatric VAD Therapy - A Multi-Institutional European Survey of the EXCOR Pediatric Investigator Group (EEPIG). (pp. S278-S278).
Heim, C., Khan, M.A., Motsch, B., Gocht, A., Ramsperger-Gleixner, M., Stamminger, T.,... Ensminger, S.M. (2017). Microvascular Integrity Can Be Preserved by Anti-Platelet Therapy and in Combination with mTOR Inhibitor. (pp. S376-S376).
Messroghli, D.R., Pickardt, T., Fischer, M., Opgen-Rhein, B., Papakostas, K., Bocker, D.,... Schubert, S. (2017). Toward evidence-based diagnosis of myocarditis in children and adolescents: Rationale, design, and first baseline data of MYKKE, a multicenter registry and study platform. American Heart Journal, 187, 133-144. https://dx.doi.org/10.1016/j.ahj.2017.02.027
Gocht, A., Ensminger, S.M., Distler, J., Spriewald, B., Ramsperger-Gleixner, M., Weyand, M., & Heim, C. (2017). Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Transplant Vasculopathy in a Murine Aortic Transplantation Model. (pp. S370-S370).
Gocht, A., Distler, J., Ensminger, S., Spriewald, B., Ramsperger-Gleixner, M., Weyand, M., & Heim, C. (2016). INFLUENCE OF SEROTONIN (5-HT) RECEPTOR TYPE 2 ANTAGONISTS ON THE DEVELOPMENT OF TRANSPLANT VASCULOPATHY IN A MODEL OF MURINE AORTIC TRANSPLANTATION. (pp. 18-18).
Schmieder, R., Gitt, A.K., Koch, C., Bramlage, P., Ouarrak, T., & Tschoepe, D. (2015). Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry. BMC Endocrine Disorders, 15(1), 23. https://dx.doi.org/10.1186/s12902-015-0020-7

Last updated on 2016-07-06 at 12:32